Evidence map›Paper›PMID 22723266›Full record

ArticleAmerican journal of physiology. Gastrointestinal and liver physiology2012

Nesfatin-1 inhibits gastric acid secretion via a central vagal mechanism in rats.

Ze-Feng Xia, Danielle M Fritze, Ji-Yao Li, Biaoxin Chai, Chao Zhang, Weizhen Zhang, Michael W Mulholland

Abstract read
In one paragraph

Article in American journal of physiology. Gastrointestinal and liver physiology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 51 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Research progress on the relationship between Nesfatin-1 and glucose metabolism.Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2024
    Review
  5. Article
  6. Article
  7. Article
  8. Calcium Signaling Pathways: Key Pathways in the Regulation of Obesity.International journal of molecular sciences · 2019
    Review
  9. Current Understanding of the Role of Nesfatin-1.Journal of the Endocrine Society · 2018
    Review
  10. Novel transmitters in brain stem vagal neurocircuitry: new players on the pitch.American journal of physiology. Gastrointestinal and liver physiology · 2018
    Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Role of NUCB2/Nesfatin-1 in the hypothalamic control of energy homeostasis.Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme · 2013
    Article
  20. The role of nesfatin-1 in the regulation of food intake and body weight: recent developments and future endeavors.Obesity reviews : an official journal of the International Association for the Study of Obesity · 2013
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Ze-Feng XiaDepartment of General Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Danielle M Fritze
Ji-Yao Li
Biaoxin Chai
Chao Zhang
Weizhen Zhang
Michael W Mulholland
University of Michigan–Ann Arbor · USUnion Hospital · CN

Funding

Obesity is a Surgical ProblemR01DK054032 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MULHOLLAND, MICHAEL W. · 1998 to 2013
$4.5M
NEUROPEPTIDE REGULATION OF ENTEROPANCREATIC FUNCTIONR01DK043225 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MULHOLLAND, MICHAEL W. · 1991 to 2003
$844k
NIDDK NIH HHS R01 DK-043225NIDDK NIH HHS R01 DK054032
6 · The paper itself

Abstract

Nesfatin-1, a novel hypothalamic peptide, inhibits nocturnal feeding behavior and gastrointestinal motility in rodents. The effects of nesfatin-1 on gastrointestinal secretory function, including gastric acid production, have not been evaluated. Nesfatin-1 was injected into the fourth intracerebral ventricle (4V) of chronically cannulated rats to identify a nesfatin dose sufficient to inhibit food intake. Nesfatin-1 (2 μg) inhibited dark-phase food intake, in a dose-dependent fashion, for >3 h. Gastric acid production was evaluated in urethane-anesthetized rats. Nesfatin-1 (2 μg) was introduced via the 4V following endocrine stimulation of gastric acid secretion by pentagastrin (2 μg·kg(-1)·h(-1) iv), vagal stimulation with 2-deoxy-D-glucose (200 mg/kg sc), or no stimulus. Gastric secretions were collected via gastric cannula and neutralized by titration to determine acid content. Nesfatin-1 did not affect basal and pentagastrin-stimulated gastric acid secretion, whereas 2-deoxy-D-glucose-stimulated gastric acid production was inhibited by nesfatin-1 in a dose-dependent manner. c-Fos immunofluorescence in brain sections was used to evaluate in vivo neuronal activation by nesfatin-1 administered via the 4V. Nesfatin-1 caused activation of efferent vagal neurons, as evidenced by a 16-fold increase in the mean number of c-Fos-positive neurons in the dorsal motor nucleus of the vagus (DMNV) in nesfatin-1-treated animals vs. controls (P < 0.01). Finally, nesfatin-induced Ca(2+) signaling was evaluated in primary cultured DMNV neurons from neonatal rats. Nesfatin-1 caused dose-dependent Ca(2+) increments in 95% of cultured DMNV neurons. These studies demonstrate that central administration of nesfatin-1, at doses sufficient to inhibit food intake, results in inhibition of vagally stimulated secretion of gastric acid. Nesfatin-1 activates DMNV efferent vagal neurons in vivo and triggers Ca(2+) signaling in cultured DMNV neurons.

Indexed as

AnimalsCalciumCalcium-Binding ProteinsDNA-Binding ProteinsEatingGastric AcidGastric MucosaMaleNerve Tissue ProteinsNucleobindinsProto-Oncogene Proteins c-fosRatsRats, Sprague-DawleyVagus NerveCalciumCalcium-Binding ProteinsDNA-Binding ProteinsNerve Tissue ProteinsNucb1 protein, ratNucleobindinsProto-Oncogene Proteins c-fos

Identifiers

PMID22723266
PMCPMC3468549
OpenAlexW2159914208

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.